• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

拉坦前列素刺激食蟹猴虹膜黑素细胞中的真黑素生成。

Latanoprost stimulates eumelanogenesis in iridial melanocytes of cynomolgus monkeys.

作者信息

Prota G, Vincensi M R, Napolitano A, Selen G, Stjernschantz J

机构信息

Department of Organic and Biological Chemistry, University of Naples Federico II, Italy.

出版信息

Pigment Cell Res. 2000 Jun;13(3):147-50. doi: 10.1034/j.1600-0749.2000.130305.x.

DOI:10.1034/j.1600-0749.2000.130305.x
PMID:10885672
Abstract

Latanoprost, the active principle of Xalatan eye drops, is a prostaglandin F2alpha analogue in widespread use for the treatment of glaucoma. During chronic treatment with the drug, an increased pigmentation of the iris was observed in both primates and man. To gain an insight into the nature of this effect, we analyzed the stroma of the irides of cynomolgus monkeys subjected to 25-38 weeks of treatment. A highly sensitive procedure, based on chemical degradation by alkaline hydrogen peroxide oxidation, or hydriodic acid hydrolysis, was developed, which allowed eumelanin and pheomelanin analysis of a single iris at a time. Untreated monkey irides were found to be essentially pheomelanic, providing further support to the recently reported occurrence of these pigments in human irides. In the Latanoprost-treated eyes, the amount of eumelanin increased from three to sevenfold, while the variation of pheomelanin did not exceed 25%. The increase in eumelanin/pheomelanin ratio in the treated eyes, as compared with the contralateral control eyes, varied from three to fivefold, and the change was statistically significant (P < 0.01; t-test). Based on the results of parallel studies, showing that Latanoprost does not induce proliferation of iridial melanocytes, and that the other pigmented layers of the iris which do not contain melanocytes are not affected by the drug, it can be concluded that the observed effect is a result of a direct interaction with the melanogenic mechanism. This probably involves activation of tyrosinase, as suggested, to account for the stimulation of melanin synthesis by related compounds, including natural prostaglandins.

摘要

拉坦前列素是适利达滴眼液的活性成分,是一种广泛用于治疗青光眼的前列腺素F2α类似物。在使用该药物的长期治疗过程中,在灵长类动物和人类中均观察到虹膜色素沉着增加。为深入了解这种效应的本质,我们分析了接受25 - 38周治疗的食蟹猴虹膜基质。我们开发了一种基于碱性过氧化氢氧化化学降解或氢碘酸水解的高灵敏度方法,该方法可一次对单个虹膜进行真黑素和褐黑素分析。未治疗的猴虹膜主要含褐黑素,这进一步支持了最近报道的这些色素在人类虹膜中的存在情况。在接受拉坦前列素治疗的眼睛中,真黑素的量增加了三到七倍,而褐黑素的变化不超过25%。与对侧对照眼相比,治疗眼的真黑素/褐黑素比值增加了三到五倍,且变化具有统计学意义(P < 0.01;t检验)。基于平行研究的结果,表明拉坦前列素不会诱导虹膜黑素细胞增殖,且虹膜中不含黑素细胞的其他色素层不受该药物影响,可以得出结论,观察到的效应是与黑素生成机制直接相互作用的结果。如前所述,这可能涉及酪氨酸酶的激活,以解释包括天然前列腺素在内的相关化合物对黑素合成的刺激作用。

相似文献

1
Latanoprost stimulates eumelanogenesis in iridial melanocytes of cynomolgus monkeys.拉坦前列素刺激食蟹猴虹膜黑素细胞中的真黑素生成。
Pigment Cell Res. 2000 Jun;13(3):147-50. doi: 10.1034/j.1600-0749.2000.130305.x.
2
Latanoprost-induced increase of tyrosinase transcription in iridial melanocytes.拉坦前列素诱导虹膜黑素细胞中酪氨酸酶转录增加。
Acta Ophthalmol Scand. 2000 Dec;78(6):618-22. doi: 10.1034/j.1600-0420.2000.078006618.x.
3
Increased pigmentation of iridial melanocytes in primates induced by a prostaglandin analogue.前列腺素类似物诱导灵长类动物虹膜黑素细胞色素沉着增加。
Exp Eye Res. 1999 Oct;69(4):431-6. doi: 10.1006/exer.1999.0718.
4
Prostaglandin-induced iridial pigmentation in primates.前列腺素诱导的灵长类动物虹膜色素沉着。
Surv Ophthalmol. 1997 Feb;41 Suppl 2:S125-8. doi: 10.1016/s0039-6257(97)80019-7.
5
Morphometric effects of long-term exposure to latanoprost.长期使用拉坦前列素的形态学效应
Ophthalmology. 2007 May;114(5):938-48. doi: 10.1016/j.ophtha.2006.10.025. Epub 2007 Feb 8.
6
Mechanism and clinical significance of prostaglandin-induced iris pigmentation.前列腺素诱导虹膜色素沉着的机制及临床意义
Surv Ophthalmol. 2002 Aug;47 Suppl 1:S162-75. doi: 10.1016/s0039-6257(02)00292-8.
7
A study of histopathological features of latanoprost-treated irides with or without darkening compared with non-latanoprost-treated irides.一项关于使用拉坦前列素治疗的虹膜(有或无颜色加深)与未使用拉坦前列素治疗的虹膜的组织病理学特征的研究。
Arch Ophthalmol. 2008 May;126(5):626-31. doi: 10.1001/archopht.126.5.626.
8
Latanoprost-induced pigmentation in human iridial melanocytes is fibroblast dependent.拉坦前列素诱导人虹膜黑素细胞色素沉着是成纤维细胞依赖性的。
Exp Eye Res. 2004 May;78(5):973-85. doi: 10.1016/j.exer.2003.12.003.
9
alpha-Methyl-p-tyrosine inhibits latanoprost-induced melanogenesis in vitro.α-甲基对酪氨酸在体外抑制拉坦前列素诱导的黑色素生成。
Exp Eye Res. 1999 Jan;68(1):85-90. doi: 10.1006/exer.1998.0581.
10
Effects of isopropyl unoprostone and latanoprost on melanogenesis in mouse epidermal melanocytes.
J Glaucoma. 2002 Feb;11(1):57-64. doi: 10.1097/00061198-200202000-00011.

引用本文的文献

1
Emerging Therapeutic Innovations for Vitiligo Treatment.白癜风治疗的新兴治疗创新
Curr Issues Mol Biol. 2025 Mar 14;47(3):191. doi: 10.3390/cimb47030191.
2
International Harmonization of Nomenclature and Diagnostic Criteria (INHAND): Nonproliferative and Proliferative Lesions of Nonrodent Ocular Tissues.国际命名与诊断标准协调组织(INHAND):非啮齿类动物眼组织的非增殖性和增殖性病变
Toxicol Pathol. 2024 Oct;52(7):368-455. doi: 10.1177/01926233241283708.
3
Up-and-Coming Drugs for the Treatment of Vitiligo.治疗白癜风的新兴药物
Ann Dermatol. 2024 Aug;36(4):197-208. doi: 10.5021/ad.24.038.
4
Efficacy of prostaglandin E2 versus prostaglandin F2 alpha assisted with narrowband-UVB in stable vitiligo.前列腺素 E2 与窄谱中波紫外线联合治疗稳定期白癜风的疗效。
Arch Dermatol Res. 2023 Nov;315(9):2647-2653. doi: 10.1007/s00403-023-02700-8. Epub 2023 Aug 18.
5
International Harmonization of Nomenclature and Diagnostic Criteria (INHAND): Non-proliferative and Proliferative Lesions of the Non-human Primate ().国际命名与诊断标准协调组织(INHAND):非人灵长类动物的非增殖性和增殖性病变()
J Toxicol Pathol. 2021;34(3 Suppl):1S-182S. doi: 10.1293/tox.34.1S. Epub 2021 Sep 28.
6
Effects of sustained daily latanoprost application on anterior chamber anatomy and physiology in mice.持续每日应用拉坦前列素对小鼠前房解剖结构和生理学的影响。
Sci Rep. 2018 Aug 30;8(1):13088. doi: 10.1038/s41598-018-31280-1.
7
Safety and efficacy of travoprost solution for the treatment of elevated intraocular pressure.曲伏前列素溶液治疗眼压升高的安全性和有效性。
Clin Ophthalmol. 2015 Apr 10;9:633-43. doi: 10.2147/OPTH.S61444. eCollection 2015.
8
Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension.前列腺素类似物在治疗眼压升高和高眼压症中的临床应用及差异效应。
Clin Ophthalmol. 2010 Jul 30;4:741-64. doi: 10.2147/opth.s10441.
9
A study of histopathological features of latanoprost-treated irides with or without darkening compared with non-latanoprost-treated irides.一项关于使用拉坦前列素治疗的虹膜(有或无颜色加深)与未使用拉坦前列素治疗的虹膜的组织病理学特征的研究。
Arch Ophthalmol. 2008 May;126(5):626-31. doi: 10.1001/archopht.126.5.626.
10
Latanoprost : an update of its use in glaucoma and ocular hypertension.拉坦前列素:其在青光眼和高眼压症治疗中的应用进展
Drugs Aging. 2003;20(8):597-630. doi: 10.2165/00002512-200320080-00005.